These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8088289)

  • 21. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
    Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging modalities in the follow-up of non-iodine avid thyroid carcinoma.
    Mallin WH; Elgazzar AH; Maxon HR
    Am J Otolaryngol; 1994; 15(6):417-22. PubMed ID: 7872477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
    Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
    Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
    Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
    Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
    Kujat C; Neidl K; Müller-Leisse C
    Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitfalls in scintigraphic detection of neuroendocrine tumours.
    Feggi L; Degli Uberti E; Pansini GC; Transforini G; Prandini N; Ambrosio MR; D'Urso AR; Faggioli R
    Eur J Nucl Med; 1992; 19(3):214-8. PubMed ID: 1315279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium 99m dimercaptosuccinic acid scintigraphy in medullary carcinoma of the thyroid.
    Scher RL; Eisele DW; Sostre S
    Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):900-3. PubMed ID: 8239354
    [No Abstract]   [Full Text] [Related]  

  • 29. Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG.
    Hirano T; Otake H; Watanabe N; Oriuchi N; Zennyouji A; Fukuda T; Endo K
    J Nucl Med; 1995 Dec; 36(12):2243-5. PubMed ID: 8523113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of medullary carcinoma of thyroid, with liver metastasis, using 99mTc DMSA(V) scintigraphy.
    Shikare S; Bashir K; Menon PS; Bapat RD; Tilve GH
    J Postgrad Med; 1995; 41(1):12-3. PubMed ID: 10740693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 32. False-positive Tc-99m pentavalent DMSA uptake in the imaging of medullary carcinoma of the thyroid.
    Lette J; Monier D; Ledoux R; Levasseur A
    Clin Nucl Med; 1991 Feb; 16(2):136-7. PubMed ID: 1848495
    [No Abstract]   [Full Text] [Related]  

  • 33. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR; Wilf LH
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
    J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
    [No Abstract]   [Full Text] [Related]  

  • 36. Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid.
    Bigsby RJ; Lepp EK; Litwin DE; Wilkinson AA; Matte GG
    Can J Surg; 1992 Aug; 35(4):388-92. PubMed ID: 1323381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
    Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
    Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of stannous oxidation in the preparation of ultrahigh-purity 99m Tc(V)-DMSA.
    Kumar V
    Nucl Med Commun; 2001 Nov; 22(11):1261-6. PubMed ID: 11606894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of imaging tests in the diagnosis of thyroid carcinoma.
    Shulkin BL; Shapiro B
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):523-43. PubMed ID: 2175703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.